ExoPTEN Clinical Manufacturing Facility
Sector: Manufacturing (Industrial) • Location: Haifa, Israel
Source: Business Insider
NurExone Biologic Inc. is planning small-scale GMP-based manufacturing of its lead candidate, ExoPTEN, in Israel to prepare for future First-in-Human Use clinical trials. The company is evaluating potential Israeli production partners for early manufacturing runs aligned with clinical requirements, with plans to transition production to the United States for scale-up.
- Status
- Prospective
- Sector
- Manufacturing (Industrial)
- Location
- Haifa, Israel
- Updated
- 22 Jul 2026
- Source
- Business Insider
ConstructChat
Ask ConstructChat about ExoPTEN Clinical Manufacturing Facility
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | NurExone Biologic Inc. is planning small-scale GMP-based manufacturing of its lead candidate, ExoPTEN, in Israel to prepare for future First-in-Human Use clinical trials. The company is evaluating potential Israeli production partners for early manufacturing runs aligned with clinical requirements, with plans to transition production to the United States for scale-up. |
Original sector | Healthcare |
Location
Country | Israel |
City | Haifa |
Source
Source | Business Insider |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial) |
Article published date | 2025-12-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project